|

Fenofibrate 200mg Clinical Trials

1 actively recruiting trial

Pipeline

Phase 2/3: 1

Top Sponsors

  • Xijing Hospital of Digestive Diseases1

Indications

  • Primary Biliary Cholangitis1
  • Liver Disease1

Other1 trial

Fenofibrate for Compensated Cirrhosis Patients With Primary Biliary Cholangitis
Phase 2/3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.